ALRN
Price
$2.00
Change
+$0.08 (+4.17%)
Updated
Dec 18, 03:51 PM (EDT)
KZIA
Price
$2.96
Change
-$0.44 (-12.94%)
Updated
Dec 18, 04:17 PM (EDT)
Ad is loading...

ALRN vs KZIA

Header iconALRN vs KZIA Comparison
Open Charts ALRN vs KZIABanner chart's image
Aileron Therapeutics
Price$2.00
Change+$0.08 (+4.17%)
Volume$150
CapitalizationN/A
Kazia Therapeutics
Price$2.96
Change-$0.44 (-12.94%)
Volume$700
CapitalizationN/A
ALRN vs KZIA Comparison Chart
Loading...
ALRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALRN vs. KZIA commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALRN is a Hold and KZIA is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (ALRN: $1.92 vs. KZIA: $3.40)
Brand notoriety: ALRN and KZIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALRN: 168% vs. KZIA: 93%
Market capitalization -- ALRN: $41.6M vs. KZIA: $14.81M
ALRN [@Biotechnology] is valued at $41.6M. KZIA’s [@Biotechnology] market capitalization is $14.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALRN’s FA Score shows that 1 FA rating(s) are green whileKZIA’s FA Score has 0 green FA rating(s).

  • ALRN’s FA Score: 1 green, 4 red.
  • KZIA’s FA Score: 0 green, 5 red.
According to our system of comparison, ALRN is a better buy in the long-term than KZIA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALRN’s TA Score shows that 4 TA indicator(s) are bullish while KZIA’s TA Score has 4 bullish TA indicator(s).

  • ALRN’s TA Score: 4 bullish, 5 bearish.
  • KZIA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALRN is a better buy in the short-term than KZIA.

Price Growth

ALRN (@Biotechnology) experienced а -10.28% price change this week, while KZIA (@Biotechnology) price change was -5.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.45%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

ALRN is expected to report earnings on May 08, 2023.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALRN($41.6M) has a higher market cap than KZIA($14.8M). KZIA YTD gains are higher at: -22.639 vs. ALRN (-37.020). KZIA has higher annual earnings (EBITDA): -17.52M vs. ALRN (-29.5M). ALRN (0) and KZIA (0) have equivalent revenues.
ALRNKZIAALRN / KZIA
Capitalization41.6M14.8M281%
EBITDA-29.5M-17.52M168%
Gain YTD-37.020-22.639164%
P/E RatioN/AN/A-
Revenue00-
Total Cash17.7MN/A-
Total Debt0N/A-
FUNDAMENTALS RATINGS
ALRN vs KZIA: Fundamental Ratings
ALRN
KZIA
OUTLOOK RATING
1..100
5252
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
51
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
9061
P/E GROWTH RATING
1..100
82100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALRN's Valuation (17) in the Pharmaceuticals Major industry is somewhat better than the same rating for KZIA (51) in the Biotechnology industry. This means that ALRN’s stock grew somewhat faster than KZIA’s over the last 12 months.

ALRN's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as KZIA (100) in the Biotechnology industry. This means that ALRN’s stock grew similarly to KZIA’s over the last 12 months.

ALRN's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as KZIA (99) in the Biotechnology industry. This means that ALRN’s stock grew similarly to KZIA’s over the last 12 months.

KZIA's Price Growth Rating (61) in the Biotechnology industry is in the same range as ALRN (90) in the Pharmaceuticals Major industry. This means that KZIA’s stock grew similarly to ALRN’s over the last 12 months.

ALRN's P/E Growth Rating (82) in the Pharmaceuticals Major industry is in the same range as KZIA (100) in the Biotechnology industry. This means that ALRN’s stock grew similarly to KZIA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALRNKZIA
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 20 days ago
78%
Bullish Trend 30 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
ALRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZUO9.950.02
+0.20%
Zuora
STZ233.090.17
+0.07%
Constellation Brands
MTLS7.91-0.05
-0.57%
Materialise NV
JXN90.37-2.08
-2.25%
Jackson Financial
GNS0.72-0.04
-5.46%
Genius Group Limited

ALRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALRN has been loosely correlated with SRZN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ALRN jumps, then SRZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALRN
1D Price
Change %
ALRN100%
-9.43%
SRZN - ALRN
44%
Loosely correlated
-4.80%
KZIA - ALRN
35%
Loosely correlated
+2.10%
INAB - ALRN
30%
Poorly correlated
+2.27%
ERNA - ALRN
29%
Poorly correlated
-3.61%
CGTX - ALRN
29%
Poorly correlated
+0.86%
More

KZIA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KZIA has been loosely correlated with HOOK. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if KZIA jumps, then HOOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZIA
1D Price
Change %
KZIA100%
+2.10%
HOOK - KZIA
66%
Loosely correlated
-1.84%
FRES - KZIA
56%
Loosely correlated
-10.54%
ALRN - KZIA
36%
Loosely correlated
-9.43%
CLNN - KZIA
33%
Poorly correlated
-7.23%
RVMD - KZIA
29%
Poorly correlated
+1.01%
More